RIO-kinase 2 is essential for hematopoiesis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0300623 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jan-Erik Messling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Neye Foundation, Kirsten og Freddy Johansens Fond.
Abstract (Originalsprache)
Regulation of protein synthesis is a key factor in hematopoietic stem cell maintenance and differentiation. Rio-kinase 2 (RIOK2) is a ribosome biogenesis factor that has recently been described an important regulator of human blood cell development. Additionally, we have previously identified RIOK2 as a regulator of protein synthesis and a potential target for the treatment of acute myeloid leukemia (AML). However, its functional relevance in several organ systems, including normal hematopoiesis, is not well understood. Here, we investigate the consequences of RIOK2 loss on normal hematopoiesis using two different conditional knockout mouse models. Using competitive and non-competitive bone marrow transplantations, we demonstrate that RIOK2 is essential for the differentiation of hematopoietic stem and progenitor cells (HSPCs) as well as for the maintenance of fully differentiated blood cells in vivo as well as in vitro . Loss of RIOK2 leads to rapid death in full-body knockout mice as well as mice with RIOK2 loss specific to the hematopoietic system. Taken together, our results indicate that regulation of protein synthesis and ribosome biogenesis by RIOK2 is essential for the function of the hematopoietic system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
- The Institute of Cancer Research, London, United Kingdom.
ORCID-Profile: Isabel Peña-Rømer, Ann Sophie Moroni, Sarah Bruestl, Kristian Helin
Förderung
- Novo Nordisk Fonden
- Neye Foundation
- Kirsten og Freddy Johansens Fond
- Institute of Cancer Research
Zitieren
APA
Messling, J. E., Peña-Rømer, I., Moroni, A. S., Bruestl, S., & Helin, K. (2024). RIO-kinase 2 is essential for hematopoiesis. PLOS ONE. https://doi.org/10.1371/journal.pone.0300623
Vancouver
Messling JE, Peña-Rømer I, Moroni AS, Bruestl S, Helin K. RIO-kinase 2 is essential for hematopoiesis. PLOS ONE. 2024. doi:10.1371/journal.pone.0300623
BibTeX
@article{Messling2024,
author = {Messling, Jan-Erik and Peña-Rømer, Isabel and Moroni, Ann Sophie and Bruestl, Sarah and Helin, Kristian},
title = {RIO-kinase 2 is essential for hematopoiesis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0300623}
}
EUVIMED